Clinical Trial Update: Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing combined dapagliflozin and exenatide vs dapagliflozin and placebo in uncontrolled type 2 diabetes assessing ectopic lipids; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steatosis Liver
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Medical University of Vienna | Conditions: Steatosis, Liver, Type2 Diabetes | Phase 4 | Status: COMPLETED